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In the late stages of replication of the simian immunodeficiency viruses (SIV), the matrix protein (MA) plays a central role
in the transport of Pr55gag to the plasma membrane, assembly of virus particles, and incorporation of the envelope
glycoprotein into particles. Targeting of Pr55gag to the plasma membrane is mediated by two motifs within the MA protein:
the N-terminal myristate and a cluster of positively charged amino acids. In this report, we characterized the assembly
phenotype of an SIV Gag mutant (L8Q) carrying the single amino acid substitution of glutamine for leucine at position 8 in
the MA domain. The hydropathic profile of the mutated MA protein indicated that the L8Q amino acid change disrupts the
hydrophobic character of the region comprising the first 10 residues of the protein. Expression of mutant L8Q Gag protein
in CV-1 cells, by means of the vaccinia virus vector system, resulted in efficient synthesis and N-myristylation of Pr55gag.
However, this mutation severely impaired particle production, as inferred from both biochemical and electron microscopy
analyses. Cellular fractionation assays revealed that in cells expressing mutant L8Q, the proportion of cytosol-associated
Pr55gag was significantly increased compared to that observed upon expression of wild-type Gag. Furthermore, mutant L8Q
Gag partitioned onto cytosol and membrane fractions in a manner similar to nonmyristylated Gag polyprotein. Taken together,
these results indicate that the L8Q mutation reduces the membrane-binding capacity of the Gag precursor. It is therefore
likely that in the SIV MA, in addition to the N-myristate group, the hydrophobicity of the neighboring region is important for
efficient association of Pr55gag with the plasma membrane. © 1998 Academic Press
INTRODUCTION
Simian immunodeficiency viruses (SIVs) are a group of
retroviruses isolated from various species of Old World
primates, which are morphologically, antigenically, and
genetically related to human immunodeficiency virus
types 1 and 2 (HIV-1 and HIV-2) (Chakrabarti et al., 1987;
Franchini et al., 1987; Desrosiers, 1988). Infection of ma-
caques with SIV results in an immunodeficiency disease
similar to AIDS in humans (Daniel et al., 1985; Letvin et
al., 1985). Due to these similar features, the SIV/macaque
system is extensively used as an animal model for the
study of HIV infection in humans.
Assembly of both HIV and SIV particles occurs at the
plasma membrane of the infected cells. The viral gag gene
products are responsible for the assembly and release of
virus particles. The SIV Gag protein is initially synthesized
as a polyprotein precursor (Pr55gag) which, as the immature
virion buds, is proteolytically cleaved by the virus-encoded
protease (PR) into the four major proteins: matrix (MA),
capsid (CA), nucleocapsid (NC), and p6, as well as two
smaller polypeptides (Henderson et al., 1990).
The MA protein, which corresponds to the N-terminal
portion of the Pr55gag, forms a shell underneath the
envelope in the mature virion (Gelderblom et al., 1987).
We have shown that the SIV MA protein plays a central
role in virus morphogenesis. Mutagenesis studies have
revealed that domains within this protein are critical for
particle formation and envelope glycoprotein incorpora-
tion into particles (Gonza´lez and Affranchino, 1995;
Gonza´lez et al., 1996). Moreover, the SIV MA self-assem-
bles into lentivirus-like particles in vivo (Gonza´lez et al.,
1993). The SIV MA is cotranslationally modified by the
addition of myristic acid to its N terminus (Henderson et
al., 1988). This modification has been shown to be in-
volved in membrane targeting of the Pr55gag (Delcham-
bre et al., 1989). However, myristate does not provide
enough energy to attach the protein to the phospholipid
bilayer (McLaughlin and Aderem, 1995), indicating that
other structural elements participate in this process. In
this regard, we have demonstrated that a cluster of basic
amino acids within the N terminus of the SIV MA (resi-
dues 26–32) is also necessary for proper membrane
targeting of the Gag precursor (Gonza´lez et al., 1993).
This highly basic region may provide additional mem-
brane-binding energy by establishing electrostatic inter-
actions with the acidic phospholipids of the plasma
membrane (Zhou et al., 1994; McLaughlin and Aderem,
1995). A similar bipartite membrane-targeting signal,
composed of myristate and a polybasic region within the
N terminus of the MA protein, directs the HIV-1 Gag
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polyprotein to the plasma membrane (Fa¨cke et al., 1993;
Yuan et al., 1993; Spearman et al., 1994; Zhou et al., 1994).
In addition, it has been shown that regions within the
HIV-1 CA and NC domains contribute to the stable mem-
brane association of Pr55gag (Platt and Haffar, 1994;
Ebbets-Reed et al., 1996). These observations point to
the involvement of several domains throughout Pr55gag
in membrane binding.
In this report, we describe the phenotype of an SIV MA
mutant carrying a mutation from leucine to glutamine at
position 8 (mutant L8Q). This amino acid change, which
disrupts the hydrophobic character of the N terminus of
the protein, drastically impaired particle production. We
found that the mutant Gag polyprotein was correctly
myristylated and thus the defect in particle production
observed for this mutant could not be explained by a lack
of Gag myristylation. The results from subcellular frac-
tionation studies performed in cells expressing the MA
mutant L8Q suggest that Leu8 may be important for
efficient interaction of the Gag polyprotein with the
plasma membrane.
MATERIALS AND METHODS
Cells and viruses
African green monkey kidney (CV-1) cells and rat em-
bryo (Rat2) TK2 cells, grown in Dulbecco’s modified
Eagle’s medium (DMEM; GIBCO BRL) supplemented
with 10% fetal bovine serum, were used to establish
recombinant vaccinia viruses. The parental vaccinia vi-
rus used for generating the recombinant viruses was the
WR strain.
Construction of recombinant vaccinia viruses
All SIV sequences were initially derived from the
SIVsmmPBj14 virus isolate (proviral clone PBj1.9) (Dewhurst
et al., 1990). The recombinant vaccinia virus expressing
the SIV wild-type (wt) gag gene and the PR domain of the
pol gene has been previously described (Gonza´lez et al.,
1993). The construction and characterization of a recom-
binant vaccinia virus directing the synthesis of a non-
myristylated form of the SIV Gag precursor have been
reported elsewhere (Gonza´lez et al., 1993). This virus
carries a mutated version of the gag gene in which the
codon for the glycine at position 2 of the gag open
reading frame was changed to alanine, thereby destroy-
ing the signal for N-myristylation. Mutagenesis was per-
formed on a SalI/PstI restriction fragment (nt 828–1646)
cloned into the pUC18 vector, which corresponds to the
first 273 amino acids of the SIV Gag polyprotein. To
substitute a glutamine residue for the leucine at position
8 in the MA protein, the SalI/PstI fragment was amplified
by PCR using a 33-mer sense primer carrying a TTG to
CAG change with respect to the wt gag gene sequence.
The presence of the mutation was confirmed by DNA
sequencing. Replacement of valine at position 7 in the
SIV MA by glutamine (mutation V7Q) was performed
following a strategy similar to that described for the
mutation L8Q. The SalI/PstI fragments carrying the de-
sired mutations were substituted for the wt counterpart
in another pUC18 vector containing the SIV wt gag and
PR genes. The mutated gag-PR sequences were excised
from the vector by digestion with SalI and HindIII restric-
tion enzymes and subcloned into the corresponding
sites in the pMJ601 vaccinia transfer vector. The mutated
gag-PR sequences were inserted into the WR virus by
homologous recombination between the plasmid trans-
fer vector pMJ601 and vaccinia virus genomic DNA es-
sentially as described (Gonza´lez et al., 1993). Selection
and purification of the recombinant vaccinia viruses
were performed as described previously (Gonza´lez et al.,
1993). Three independent recombinant vaccinia viruses
for each mutant were initially screened to be sure that
their gag products exhibited the same phenotype.
Protein expression and metabolic radiolabeling
Confluent monolayers of CV-1 cells (35-mm-diameter
petri dishes) were infected with the recombinant vac-
cinia viruses at a multiplicity of infection of 5 PFU per
cell. At 14 h postinfection (h.p.i.), the medium was
changed to methionine- and cysteine-deficient DMEM
(GIBCO BRL) supplemented with 3% fetal bovine serum
containing 100 mCi/ml of [35S]methionine/cysteine mix
(.1000 Ci/mmol, EXPRE35S35S protein labeling mix;
NEN) and cells were radiolabeled for 3–4 h. To follow the
kinetics of Gag processing and particle release, pulse–
chase experiments were performed. To this end, sets of
identically infected cells were pulse-labeled with 250
mCi/ml of the [35S]methionine/cysteine mix for 20 min.
The labeling medium was removed and replaced with
complete DMEM (5% fetal bovine serum) and incubated
for various lengths of time. For [3H]myristic acid labeling,
infected cells were incubated at 14 h.p.i. in complete
medium containing 150 mCi/ml [9,10-3H (N)]myristic acid
(16 Ci/mmol; NEN) for 6 h. Metabolically labeled cells
were washed with cold phosphate-buffered saline (PBS)
and lysed at 4°C in 100 ml TNN lysis buffer [50 mM
Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 1 mM phe-
nylmethylsulfonyl fluoride (PMSF), 10 mg/ml aprotinin].
Lysates were spun at 12,000 g for 2 min and the post-
nuclear supernatants were subjected to immunoprecipi-
tation. Methods used in this study for the pelleting of
labeled virus-like particles in an ultracentrifuge, for im-
munoprecipitation of cell- and particle-associated pro-
teins with pooled sera from SIV-infected macaques, and
for protein analysis by SDS–polyacrylamide gel electro-
phoresis (SDS–PAGE) and autoradiography have been
described previously (Gonza´lez et al., 1993; Gonza´lez
and Affranchino, 1995). Quantitation of the amount of
35S-labeled proteins was performed by excising each
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band from the dried gels after fluorography and measur-
ing its radioactivity in a liquid scintillation counter.
Cell fractionation studies
CV-1 cells grown on 60-mm-diameter dishes were
infected with the recombinant vaccinia viruses at a mul-
tiplicity of 5 PFU per cell. At 13–14 h.p.i., the infected cells
were metabolically labeled with the [35S]methionine/cys-
teine mix at 100 mCi/ml for 3 h. Cells were rinsed twice
with ice-cold PBS, scraped, pelleted by centrifugation at
500 g for 5 min, and resuspended in swelling solution [20
mM Tris–HCl (pH 7.5), 10 mM KCl, 1 mM EDTA, 1 mM
PMSF, 10 mg/ml aprotinin]. The cells were allowed to
swell in this buffer for 20 min on ice and were then
disrupted by pulling the cell suspension through a 27-
gauge needle (0.4 mm 3 13 mm) 25 times. The nuclei
and unbroken cells were removed by centrifugation
twice at 1000 g for 5 min each time. The resulting super-
natant was divided into equal portions. One-half was
adjusted to 0.15 M NaCl whereas the other half was
adjusted to 1 M NaCl. Both fractions were incubated on
ice for 10 min. Samples were centrifuged at 100,000 g for
30 min at 4°C. The membrane pellets were resuspended
in 100 ml TNN lysis buffer. The supernatants were col-
lected and concentrated by ultrafiltration in Centricon-10
microconcentrators (Amicon Inc.). The concentrated
samples were adjusted to 13 TNN buffer. Equal portions
of pellet and supernatant fractions were assayed for SIV
proteins by immunoprecipitation and analyzed by SDS–
PAGE. The amount of labeled Pr55gag in each fraction
was quantitated as described above.
Electron microscopy
CV-1 cells were infected with the recombinant vaccinia
viruses as described above. At 22–24 h.p.i., cells were
prepared for morphology by fixation with 2.5% glutaral-
dehyde in cacodylate buffer [0.1 M cacodylate (pH 7.2), 2
mM CaCl2, 2 mM MgCl2] for at least 24 h, postfixed in 1%
osmium tetroxide (in cacodylate buffer), and then treated
with 0.5% aqueous uranyl acetate. Araldite embedding
and sectioning were performed as described previously
(Hockley et al., 1988). Sections were examined with a
Philips 210C electron microscope operating at 80 kV.
RESULTS
Effect of the L8Q mutation on particle production
Our previous structure–function analyses of the SIV
MA have mainly focused on the C-terminal two-thirds
of the molecule (Gonza´lez et al., 1993, 1996; Gonza´lez
and Affranchino, 1995). Mutant L8Q is one of a series
of SIV MA mutants that was generated by site-directed
mutagenesis to assess the role in virus morphogene-
sis of highly conserved residues within the N-terminal
third of this protein. In mutant L8Q, a leucine residue
at position 8 within the MA protein was substituted by
glutamine. This amino acid change was introduced in
a construct (Gag-PR) encompassing the complete gag
gene in addition to the pol region coding for the PR
domain, as described under Materials and Methods.
This construct was then used to generate a recombi-
nant vaccinia virus expressing the mutated Gag
polyprotein, whose phenotype was then characterized.
To determine whether the L8Q mutation introduced
into the SIV MA had any effect on the synthesis and
processing of the Gag polyprotein, CV-1 cells were
infected with the recombinant vaccinia virus express-
ing the mutant L8Q in parallel with the recombinant
virus directing the synthesis of wt Gag. After metabolic
labeling, the Gag-specific proteins were immunopre-
cipitated from cell lysates with pooled sera from SIV-
infected macaques (Fig. 1A). Cells infected with the
MA mutant L8Q expressed steady-state levels of Gag
precursor similar to those observed in cells express-
ing wt Gag. In addition, expression of the MA mutant
resulted in essentially wild-type levels of the mature
Gag polypeptides, MA and CA.
To assess the effect of the L8Q mutation on particle
assembly and release, the particulate material released
into the culture medium of the infected cells was pelleted
through a 20% sucrose cushion and assayed for SIV Gag
proteins by immunoprecipitation. As shown in Fig. 1B,
mutation L8Q drastically reduced the levels of extracel-
lular particles. In several independent experiments, only
trace amounts of Pr55gag were detected in the particulate
fraction purified from the medium of mutant L8Q-infected
cell cultures.
FIG. 1. Effect of L8Q mutation on particle production. Cells infected
with vaccinia viruses expressing wt Gag (WT) or mutant L8Q (L8Q)
proteins were metabolically labeled with [35S]methionine/cysteine mix
for 3 h. Viral proteins were immunoprecipitated from cell lysates (A) and
the particulate fraction purified from the clarified culture supernatants
(B) and analyzed by SDS–PAGE. The mobilities of the Gag precursor
(Pr55), CA, and MA proteins are indicated. The positions of protein size
markers (in kDa) are shown on the right.
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Kinetics of mutant L8Q Gag polyprotein processing
Since the experiments described above compared the
steady-state levels of intracellular and particle-associ-
ated Gag proteins, we next examined the kinetics of Gag
synthesis, processing, and particle release. To this end,
pulse–chase experiments were performed in which cells
expressing either wt Gag or mutant L8Q were pulse-
labeled for 20 min and then chased in complete medium
for 90 and 240 min (Fig. 2). When cells expressing wt Gag
were pulse-labeled, the band of Pr55gag was detected
(Fig. 2A, wt, lane P). After a 90-min chase, the amount of
pulse-labeled Gag molecules decreased by 83% and
cell-associated CA and MA proteins were observed (lane
1). After a 240-min chase period, 96% of the wt Gag
precursor was processed (lane 2). When the particulate
fraction of the culture medium was analyzed during the
chase period, increasing amounts of extracellular
Pr55gag and CA proteins were detected (Fig. 2B, wt,
lanes 1–2).
In cells expressing MA mutant L8Q a different pattern
of Gag polyprotein processing and particle release was
observed. The mutant L8Q Gag precursor was pro-
cessed into mature proteins with a slower kinetics than
that of wt Gag (Fig. 2A, L8Q, lanes P–2). Indeed, about 42
and 15% of pulse-labeled Pr55gag molecules remained
unprocessed after a 90-min and a 240-min chase, re-
spectively. Quantitation of the intracellular levels of the
wt and mutant L8Q Gag polyproteins over time revealed
that the mutant Gag had a half-life of 60 min, compared
to 36 min for wt Gag. The slower processing kinetics of
mutant L8Q Gag precursor with respect to that of wt Gag
may result from inefficient membrane binding (see be-
low). Indeed, the amount of Gag and Gag-Pol polypro-
teins accumulated at the plasma membrane influences
the enzymatic activity of the viral PR (Mergener et al.,
1992).
When the cultures of mutant L8Q-infected cells were
analyzed for extracellular particle release, no evidence of
particle-associated Gag polypeptides was obtained (Fig.
2B, L8Q). A similar impairment in particle release was
observed in pulse–chase experiments with chase peri-
ods as long as 8 h (data not shown). Our results therefore
indicate that the defect in particle production exhibited
by mutant L8Q cannot be attributed to either Gag pre-
cursor instability or a delay in particle release.
Electron microscopic analysis of cells expressing
mutant L8Q
The biochemical experiments described above sug-
gested that mutant L8Q had a major defect in particle
production. To obtain additional information on the phe-
notype of this mutant, electron microscopic studies of
cells expressing wt Gag or mutant L8Q were carried out
(Fig. 3). Consistent with our previous report (Gonza´lez et
al., 1993), cells infected with recombinant vaccinia virus
expressing wt Gag showed numerous typical lentiviral
particles budding at the plasma membrane (Fig. 3A). By
contrast, in thin sections of cells expressing mutant L8Q
extracellular particles adjacent to the plasma membrane
were rarely seen (Fig. 3B). Moreover, Gag-specific struc-
tures arrested in the budding process were not ob-
served. Occasionally, one particle could be seen bud-
FIG. 2. Kinetics of Gag polyprotein processing and particle release of mutant L8Q. (A) Analysis of intracellular viral proteins. CV-1 cells expressing
wt Gag (WT) or mutant L8Q (L8Q) proteins were pulse-labeled for 20 min (lanes P) and chased for 90 min (lanes 1) and 240 min (lanes 2). At each
time point, cells were lysed and SIV-specific proteins were immunoprecipitated with pooled sera of infected macaques and analyzed by SDS–PAGE.
(B) Analysis of particle-associated viral proteins. The culture supernatants of cells expressing wt Gag or mutant L8Q proteins were collected following
90-min (lanes 1) and 240-min (lanes 2) chases. Particles were purified by ultracentrifugation through a sucrose cushion and the presence of viral
proteins was analyzed by immunoprecipitation and SDS–PAGE.
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ding into intracellular vesicles (data not shown). These
data indicate that mutation L8Q does not redirect particle
assembly to intracellular sites.
Effect of the L8Q mutation on Gag polyprotein
myristylation
N-myristoyl transferases are able to sense the physi-
cochemical properties of the amino acids occupying at
least the first nine residues of the nascent polypeptides
(Johnson et al., 1994). Moreover, mutations affecting the
very N terminus of the p60src oncoprotein have been
shown to block the myristylation of this protein (Kaplan et
al., 1988). Therefore, the possibility existed that the as-
sembly-deficient phenotype exhibited by mutant L8Q
could be the result of inefficient N-myristylation of the
mutant Gag precursor. To examine this possibility, cells
infected with the recombinant vaccinia virus expressing
wt Gag or mutant L8Q were metabolically labeled with
either [35S]methionine/cysteine mix for 2 h or [3H]myristic
acid for 6 h. Cell lysates were assayed for SIV proteins by
immunoprecipitation and SDS–PAGE. Both 35S- and 3H-
labeled samples were analyzed in the same gel in order
to compare the electrophoretic mobilities of the radiola-
beled bands. As shown in Fig. 4, lysates of mutant
L8Q-expressing cells exhibited myristylated proteins that
comigrated with the Pr55gag and MA polypeptides seen
in 35S-labeled samples (compare Figs. 4A and 4B). Inter-
estingly, the [3H]myristic-labeled mutant proteins accu-
mulated to a larger extent than the wt Gag proteins (Fig.
4B). This difference may reflect the inefficient release of
the L8Q Gag polypeptides into the medium. A similar
intracellular accumulation of myristylated Gag proteins
has been observed in mutant Moloney murine leukemia
viruses deficient in particle assembly (Granowitz and
Goff, 1994). Therefore, our results demonstrate that mu-
tation L8Q does not interfere with the N-myristylation of
Pr55gag.
Effect of the L8Q mutation on the subcellular
localization of mutant Gag proteins
In order to assemble into particles, the SIV Gag
polyprotein must be transported to and associated with
the cell plasma membrane. Hydropathicity analysis of
the N terminus of the SIV MA protein reveals that the
region comprising the first 10 residues is hydrophobic
(Fig. 5A). This region could potentially mediate hydropho-
bic interactions between the Gag precursor and the lipid
bilayer, in addition to those provided by the myristate
moiety. The hydrophobic character of this domain is
disrupted by the L8Q mutation (Fig. 5B). Based on these
data, it is tempting to speculate that replacement of
FIG. 3. Electron micrographs of CV-1 cells expressing wt Gag (A) or mutant L8Q (B) proteins. Cells were harvested at 24 h.p.i. Arrows in B indicate
particles adjacent to the plasma membrane. Bar, 100 nm.
FIG. 4. Effect of L8Q mutation on Pr55gag myristylation. CV-1 cells
infected with vaccinia viruses expressing wt Gag (WT) or mutant L8Q
(L8Q) proteins were metabolically labeled with [35S]methionine/cys-
teine mix for 2 h (A) or [3H]myristic acid for 6 h (B). Cells were lysed in
TNN buffer and assayed for the presence of viral proteins by immuno-
precipitation. Both 35S- and 3H-labeled samples were analyzed in the
same gel separated by several lanes. (A) A 2-day exposure of the
35S-labeled samples; (B) a 15-day exposure of the 3H-labeled samples.
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leucine 8 with glutamine may impair the stable mem-
brane association of the Gag polyprotein by preventing
the formation of additional hydrophobic contacts.
To examine the ability of mutant L8Q Gag precursor to
interact in vivo with cellular membranes, cell fraction-
ation studies were performed. For comparison, we also
analyzed the partitioning with the cytosol and membrane
fractions of wild-type and nonmyristylated Pr55gag pro-
teins. Similar assays have been extensively used to de-
fine membrane associations of HIV-1 Gag (Bryant and
Ratner, 1990; Park and Morrow, 1992; Yuan et al., 1993;
Zhou and Resh, 1996). Cells infected with recombinant
vaccinia viruses expressing wt Gag, nonmyristylated
(Myr2) Gag, or mutant L8Q Gag were metabolically la-
beled for 3 h. Cells were swollen in hypotonic buffer,
physically ruptured, and fractionated into cytosolic and
membrane fractions in the presence of 0.15 M NaCl.
Each fraction was adjusted to 13 TNN lysis buffer and
subjected to immunoprecipitation with pooled sera from
SIV-infected macaques. Proteins were then resolved by
SDS–PAGE. A representative experiment of cell fraction-
ation is illustrated in Fig. 6A. Furthermore, Fig. 6B shows
the quantitative analysis (three independent experi-
ments) of the partitioning onto cytosol and membrane
fractions of wt, Myr2, and mutant L8Q Pr55gag. In all
three cases, a major proportion of the Gag precursor
was found to be associated with the membrane fraction.
However, significant differences in the amount of cy-
tosol-associated Pr55gag were observed when either
Myr2 or L8Q Gag mutants were compared to wt Gag. In
the case of wt Gag, the precursor localized almost en-
tirely to the membrane fraction; only 7% was associated
with the cytosolic fraction. By contrast, about 40% of the
Myr2 Gag precursor was present in the cytosol. A similar
proportion of soluble Myr2 Gag protein has been re-
ported by others (Park and Morrow, 1992). In the case of
mutant L8Q, we found that its subcellular distribution
resembled that of Myr2 Gag. Indeed, nearly 30% of mu-
tant L8Q Gag precursor partitioned to the cytosolic frac-
tion. Furthermore, the Gag-processing intermediates as
well as the CA and MA products of both mutant L8Q and
nonmyristylated Gag accumulated as membrane-free
soluble forms. Cell fractionation experiments performed
in the presence of 1 M NaCl did not significantly affect
the subcellular distribution of either Myr2 or L8Q Gag
mutants (data not shown). Taken together, these results
suggest that mutation L8Q reduces the membrane-bind-
ing efficiency of the Gag precursor.
The observation that in mutants Myr2 and L8Q a
significant proportion of Gag precursor appeared in a
membrane-bound form may be due to the copelleting in
the membrane fraction of Gag aggregates and/or Gag
proteins precipitated with cytoskeleton components.
Mutation of MA amino acid 7
The experiments described above clearly suggested
that, in addition to the N-myristate moeity, the neighbor-
ing hydrophobic region in the SIV MA protein is impor-
tant for efficient Gag–membrane interaction and particle
formation. If so, mutation of Val7, the residue other than
Leu8 that contributes to the hydrophobic character of the
N terminus of the SIV MA, should impair particle produc-
tion. To address this issue, we constructed an SIV Gag
mutant carrying the substitution of glutamine for valine at
position 7 in the MA domain (mutant V7Q). CV-1 cells
were infected with the recombinant vaccinia virus ex-
pressing the mutant V7Q in parallel with the recombinant
virus expressing wt Gag and metabolically labeled as
described under Materials and Methods. Analysis of cell
lysates showed that MA mutant V7Q expressed levels of
Pr55gag as well as CA and MA proteins comparable to
those of wt Gag (Fig. 7A). However, no SIV Gag proteins
were detected in the particulate fraction purified from
culture supernatants of mutant V7Q-infected cells (Fig.
FIG. 5. Hydropathy profiles of the N terminus (first 20 amino acids) of
wt MA (A) and mutant L8Q MA (B) calculated according to Kyte and
Doolittle (1982). Scores above the dotted line denote hydrophobicity.
The amino acid sequence of each MA protein (in single-letter code) is
shown on the X-axis. The amino acid at position 8 in both MA se-
quences is boxed.
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7B). These results indicate that, as expected, mutation
V7Q, which disrupts the hydrophobicity of the SIV MA N
terminus, severely affects particle production. This effect
on particle formation cannot be attributed to inefficient
Gag myristylation since mutant V7Q was found to be
N-myristylated (data not shown).
DISCUSSION
The transport of viral proteins from their site of syn-
thesis to their site of function is an important event in the
virus life cycle. The SIV gag gene is initially expressed in
the cytoplasm of the infected cells as a polyprotein
precursor that is then targeted to the plasma membrane
where it assembles into particles. The MA domain of SIV
Pr55gag plays a dual role in this process by being in-
volved in both assembly and membrane targeting of the
Gag precursor (Delchambre et al., 1989; Gonza´lez et al.,
1993).
In this report, we show that replacement of leucine 8
with glutamine in the SIV MA severely impaired particle
production. In electron micrographs of cells expressing
mutant L8Q, only a few extracellular particles were ob-
served. There was no indication of particles arrested in
the process of budding, and no accumulation of intracel-
lular capsids was seen. A detailed biochemical charac-
terization of this MA mutant demonstrated that its phe-
notype could not be attributed to inefficient Gag
polyprotein synthesis or precursor instability. Further-
more, the possibility that this mutation might affect N-
protein myristylation was ruled out by the demonstration
that [3H]myristic acid was efficiently incorporated into the
mutant L8Q Gag protein. Subcellular fractionation as-
says showed that mutation L8Q increased by fourfold the
proportion of cytosol-associated Pr55gag. Indeed, the
partitioning of mutant L8Q Gag onto the cytosol and
membrane fractions was found to be similar to that of
nonmyristylated Gag. These observations indicate that
mutation L8Q reduces the membrane-binding capacity of
the Gag precursor despite the fact that the mutated Gag
polyprotein is efficiently myristylated and bears an intact
polybasic region.
The observation that the single amino acid substitu-
FIG. 6. Subcellular localization of the mutant L8Q Gag proteins. CV-1 cells infected in parallel with vaccinia viruses expressing wt Gag (wt),
nonmyristylated Gag (Myr2), or mutant L8Q (L8Q) proteins were metabolically labeled for 3 h. Cells were lysed and fractionated into cytosolic (S) and
membrane (P) fractions as described under Materials and Methods. SIV-specific proteins were immunoprecipitated from each fraction with pooled
sera of infected macaques and subjected to SDS–PAGE and autoradiography. (A) Typical autoradiogram. (B) Graphic representation of the relative
amount of Pr55gag present in the cytosolic and membrane fractions purified from cells expressing wt Gag, nonmyristylated Gag, and mutant L8Q
proteins. The Pr55gag band was excised from the dried gels and its radioactivity quantitated as described under Materials and Methods. The results
represent the average from three independent experiments. Error bars indicate the standard deviations of the mean.
FIG. 7. Effect of mutation V7Q on particle production. Cells infected
with vaccinia viruses expressing wt Gag (WT) or mutant V7Q (V7Q)
proteins were metabolically labeled with [35S]methionine/cysteine mix
for 4 h. Viral proteins were immunoprecipitated from cell lysates (A) and
the particulate fraction purified from the clarified culture supernatants
(B) and analyzed by SDS–PAGE. The mobilities of the Gag precursor
(Pr55), CA, and MA proteins are indicated.
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tion L8Q disrupts the hydrophobic character of the first
10 amino acids of the SIV MA suggests that the hydro-
phobicity of this region is important for the membrane
association of the Gag precursor and, therefore, for its
assembly into particles. This is supported by the assem-
bly-deficient phenotype observed for the Gag polyprotein
carrying the mutation V7Q which also disrupts the hy-
drophocity of the Gag N-terminal region. In this regard, it
has been shown that replacement of the first 14 amino
acids of p60v-src with those of HIV-1 Gag was sufficient
for membrane interaction of the Gag-Src chimera in vitro
and in vivo (Zhou et al., 1994). The sequence provided by
HIV-1 in this construct contained the myristylation signal
but lacked the cluster of basic residues located down-
stream in the HIV-1 Gag sequence. Since myristylation
per se was found to be insufficient for membrane binding
of the Gag–Src chimera, it was suggested that hydropho-
bic residues within the first 14 amino acids of HIV-1 Gag
might enhance the interaction with the plasma mem-
brane (Zhou et al., 1994). However, the identification of
the specific residues that might influence the interaction
with the lipid bilayer was not addressed in that study. We
now demonstrate the relevance of MA Leu8 to the mem-
brane-binding efficiency of the SIV Gag polyprotein. The
fact that Leu8 is highly conserved among the MA pro-
teins of different HIV-1 isolates (Myers et al., 1993) sug-
gests that this residue may also be important in HIV-1 for
proper Gag interaction with the plasma membrane. It is
noteworthy that mutations affecting a hydrophobic region
within the N terminus of Moloney murine leukemia virus
MA protein (residues 7–14) blocked virion release with-
out preventing N-terminal myristylation (Granowitz and
Goff, 1994). It is therefore likely that the presence of a
membrane-binding competent region composed of the
N-myristate and neighboring hydrophobic residues is a
common feature of several retroviral MA proteins. In the
case of SIV and HIV-1, this hydrophobic domain acts in
concert with the N-terminal polybasic region to promote
the correct targeting of the Gag precursor to the plasma
membrane. Furthermore, it is important to consider that,
at least in HIV-1, additional interactions provided by the
CA and NC domains have been shown to contribute to
the stable membrane association of the Gag precursor
(Platt and Haffar, 1994; Ebbets-Reed et al., 1996).
Transport of the SIV Gag polyprotein to the plasma
membrane appears to be a highly regulated process.
Our work points to an important role of Leu8 in the
membrane association of the SIV Gag precursor. This
amino acid may establish hydrophobic interactions with
the lipid bilayer which may stabilize the Gag–membrane
association mediated by the myristoyl group. Alterna-
tively, Leu8 may be necessary to maintain the proper
Gag precursor conformation that ensures exposure of
the myristoyl group, thereby allowing its insertion into the
lipid bilayer. However, the fact that in the crystal structure
of the SIV MA the first nine residues are markedly dis-
ordered (Rao et al., 1995) suggests that the hydrophobic
character of this region rather than its particular confor-
mation may be important for efficient membrane binding
of the Gag precursor.
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